{
    "SPADE_UN_29788": {
        "Sequence Information": {
            "Peptide Name": "Arenicin-1 [V8R]",
            "Sequence": "RWCVYAYRRVRGVLVRYRRCW",
            "Sequence Length": 21,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "5M9U",
            "UniProt Entry": [
                {
                    "uniprotId": "Q5SC60",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/Q5SC60",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Design of antimicrobial peptide arenicin analogs with improved therapeutic indices.",
                    "Pubmed ID": "25557880",
                    "Reference": "J Pept Sci. 2015;21:105-113",
                    "Author": "Panteleev PV, Bolosov IA, Balandin SV, Ovchinnikova TV",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/25557880"
                },
                {
                    "Title": "Dimerization of the antimicrobial peptide arenicin plays a key role in the cytotoxicity but not in the antibacterial activity.",
                    "Pubmed ID": "27940358",
                    "Reference": "Biochem Biophys Res Commun. 2017;482:1320-1326",
                    "Author": "Panteleev PV, Myshkin MY, Shenkarev ZO, Ovchinnikova TV",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/27940358"
                }
            ],
            "Mass": 2817.35,
            "PI": 11.3,
            "Net Charge": 7,
            "Hydrophobicity": -0.49,
            "Frequent Amino Acids": "RVY",
            "Absent Amino Acids": "DEFHIKMNOPQSTU",
            "Basic Residues": 7,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 8,
            "Polar Residues": 13,
            "Positive Residues": 7,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_UN_29788",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_11684",
                    "Similarity": 1.0,
                    "Sequence": "RWCVYARVRGVRYRRCW"
                },
                {
                    "SPADE_ID": "SPADE_UN_19236",
                    "Similarity": 1.0,
                    "Sequence": "RWCVYARVRGVRYRRCW"
                },
                {
                    "SPADE_ID": "SPADE_UN_29788",
                    "Similarity": 1.0,
                    "Sequence": "RWCVYAYRRVRGVLVRYRRCW"
                }
            ],
            "Hemolytic Activity": "Human erythrocytes:10% Hemolysis=125.0 µM",
            "Target Organism": "Staphylococcus aureus 209P(MIC=6.25µM),Escherichia coli C600(MIC=1.56µM),Pseudomonas aeruginosa PAO1(MIC=1.56µM),Bacillus subtilis VKM B-886(MIC=0.62µM),Bacillus subtilis VKM B-886(MBC=0.62µM),Staphylococcus aureus ATCC 33591(MIC=0.31µM),Escherichia coli ML-35p(MIC=0.08µM),Escherichia coli ML-35p(MIC=0.31µM),Escherichia coli(MIC=0.08-0.16µM),Escherichia coli(MBC=0.08-0.16µM),Pseudomonas aeruginosa(MIC=0.62-1.25µM),Pseudomonas aeruginosa(MBC=1.25µM),Klebsiella pneumoniae(MIC=0.62-1.25µM),Klebsiella pneumoniae(MBC=0.62-1.25µM)"
        }
    }
}